NIH promotes use of lower cost drugs for hypertension
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7439.539 (Published 04 March 2004) Cite this as: BMJ 2004;328:539
- David Spurgeon
- Quebec
Dr Paul Whelton is worried because doctors are not implementing trial findings
Credit: IAN JACKSON/WESTERN MORNING NEWS
The US National Institutes of Health is planning to use some 600 prominent doctors in the United States, Canada, and Puerto Rico to promote the use of lower cost drugs to treat hypertension.
Currently, the cost of antihypertensive drugs in the United States amounts to about $15bn (£8bn; €12bn), accounting for 10% of the country's total spending on drugs. The institutes' $3.7m initiative is the first time it has tried to promote a change in …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.